[go: up one dir, main page]

MEP37108A - Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate - Google Patents

Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate

Info

Publication number
MEP37108A
MEP37108A MEP-371/08A MEP37108A MEP37108A ME P37108 A MEP37108 A ME P37108A ME P37108 A MEP37108 A ME P37108A ME P37108 A MEP37108 A ME P37108A
Authority
ME
Montenegro
Prior art keywords
piperazinyl
biphenyl
benzoxazolone
monomethansulfonate
metheyl
Prior art date
Application number
MEP-371/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Klaas Zwier
Gerrit Klein
Irene Eijgendaal
Horst-Van Amstel Maria J L Ter
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP37108(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of MEP37108A publication Critical patent/MEP37108A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
MEP-371/08A 2003-08-18 2004-08-18 Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate MEP37108A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49570803P 2003-08-18 2003-08-18
EP03102573 2003-08-18
PCT/EP2004/051816 WO2005016898A2 (en) 2003-08-18 2004-08-18 Stable polymorph of bifeprunox mesilate

Publications (1)

Publication Number Publication Date
MEP37108A true MEP37108A (en) 2011-02-10

Family

ID=34924088

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-371/08A MEP37108A (en) 2003-08-18 2004-08-18 Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate

Country Status (26)

Country Link
EP (1) EP1656358B1 (xx)
JP (1) JP2007502802A (xx)
CN (1) CN100422159C (xx)
AR (1) AR045362A1 (xx)
AT (1) ATE499348T1 (xx)
AU (1) AU2004265104B2 (xx)
BR (1) BRPI0413617A (xx)
CA (1) CA2536149C (xx)
DE (1) DE602004031534D1 (xx)
DK (1) DK1656358T3 (xx)
EA (1) EA008182B1 (xx)
ES (1) ES2361508T3 (xx)
IS (1) IS8279A (xx)
ME (1) MEP37108A (xx)
MX (1) MXPA06001881A (xx)
MY (1) MY139462A (xx)
NO (1) NO20061265L (xx)
NZ (1) NZ545415A (xx)
PL (1) PL1656358T3 (xx)
PT (1) PT1656358E (xx)
RS (1) RS20060113A (xx)
SI (1) SI1656358T1 (xx)
TW (1) TWI336695B (xx)
UA (1) UA85562C2 (xx)
WO (1) WO2005016898A2 (xx)
ZA (1) ZA200601399B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
CA2654557A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and l-dopa
EA200970239A1 (ru) 2006-08-31 2009-08-28 Солвей Фармасьютикалс Б.В. Режим титрования бифепрунокса для лечения шизофрении и наборы для применения в этой области
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
US9675101B2 (en) 2013-03-15 2017-06-13 Whirlpool Corporation High performance adjustable juicer with whole foods feed chute

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340173T1 (de) * 1996-03-29 2006-10-15 Duphar Int Res Piperazin- und piperidin- derivate
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
AU2003999A (en) * 1997-12-19 1999-07-12 Advanced Research And Technology Institute, Inc. Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
AR034206A1 (es) * 2001-02-16 2004-02-04 Solvay Pharm Bv Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos

Also Published As

Publication number Publication date
WO2005016898A2 (en) 2005-02-24
SI1656358T1 (sl) 2011-06-30
RS20060113A (sr) 2008-09-29
EA200600442A1 (ru) 2006-08-25
NZ545415A (en) 2009-11-27
AU2004265104A1 (en) 2005-02-24
TWI336695B (en) 2011-02-01
BRPI0413617A (pt) 2006-10-17
PL1656358T3 (pl) 2011-07-29
MY139462A (en) 2009-10-30
PT1656358E (pt) 2011-05-12
CN1835935A (zh) 2006-09-20
TW200513462A (en) 2005-04-16
CA2536149A1 (en) 2005-02-24
AU2004265104B2 (en) 2009-06-04
DE602004031534D1 (de) 2011-04-07
ATE499348T1 (de) 2011-03-15
NO20061265L (no) 2006-05-09
JP2007502802A (ja) 2007-02-15
UA85562C2 (xx) 2009-02-10
CN100422159C (zh) 2008-10-01
IS8279A (is) 2006-01-31
MXPA06001881A (es) 2006-05-17
ZA200601399B (en) 2007-04-25
EP1656358B1 (en) 2011-02-23
AR045362A1 (es) 2005-10-26
WO2005016898A3 (en) 2005-04-07
CA2536149C (en) 2011-03-22
WO2005016898B1 (en) 2005-05-19
ES2361508T3 (es) 2011-06-17
EA008182B1 (ru) 2007-04-27
DK1656358T3 (da) 2011-05-30
EP1656358A2 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
WO2003004480A3 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
TW200621762A (en) Novel compounds
ATE378332T1 (de) Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon
MEP13408A (en) Cdk inhibiting pyrimidines, production thereof and their use as medicaments
JP2005510473A5 (xx)
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
MY138352A (en) Benzothiazole derivatives
WO2008097538A8 (en) Therapeutic agents
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
NO20061151L (no) Succinat- og malonatsalt av trans-4-((ir,3s)-6-klor-3-fenylindan-i-yl)-1,2,2-trimetylpiperazin og anvendelsen som et medikament
ES2192264T3 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina.
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
CA2252898A1 (en) Mesylate dihydrate salts of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one(=ziprasidone), its preparation and its use as dopamine d2 antagonist
MY169274A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
JP2009532504A5 (xx)
DE60329330D1 (de) Piperidin- und pyrrolidin-derivate alsantagonisten des histamin-h3-rezeptors
EA200971086A1 (ru) Фармацевтические композиции и способ лечения шизофрении
MA46268A (fr) Dérivés de 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma
EP1817311A4 (en) 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS AS BETA SEKTRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER
MEP37108A (en) Stable polymorph of bifeprunox mesilate (7-[4-([1,1'-biphenyl]-3-yl-metheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethansulfonate
DE602005027677D1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
DE50312523D1 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
DK1853232T3 (da) Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv